A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

NCT02319772 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Filovirus Infections
Ebola Virus Infection

Interventions

DRUG: BCX4430
DRUG: Placebo

Sponsor

BioCryst Pharmaceuticals

Collaborators

[object Object]